The interaction of human DNA topoisomerase I (topo I) with specific se
quence oligodeoxynucleotides (ODNs) of different length and structure
has been investigated. All the ODNs used were shown to be effective en
zyme inhibitors and to inhibit the topo I catalyzed relaxation of scDN
A in a competitive manner. Among two DNA regions (A and B) required fo
r topo I-mediated DNA cleavage, the former was found to display the hi
gher affinity for the enzyme. The enzyme's affinity for ODNs correspon
ding to the scissile strand (five and nine nucleotide units in length)
is about 2-4 orders of magnitude higher than that for non-specific OD
Ns of the same length. Topo I can efficiently recognize even extremely
short specific ODNs containing only two or three bases (AGA and pAG,
K-i = 15 and 60 mu M, respectively): the sequence AAGA (K-i = 10 mu M)
is essential for tight DNA binding to topo I. The affinities of ODNs
corresponding to the non-scissile strand are significantly lower. The
ligand's affinity increases with its length. Additionally, about a ten
-fold enhancement of specific sequence affinity occurs due to stable d
uplex formation during enzyme preincubation with ligands before additi
on of scDNA. We believe the possibility of using the short specific ol
igonucleotides and its derivatives as topoisomerase I-targeting drugs
could not be excluded. (C) Societe francaise de biochimie et biologic
moleculaire/Elsevier, Paris.